Exceptional Response to Immunotherapy-based Treatment in Compound EGFR-Mutated Oligometastatic Pulmonary Sarcomatoid Carcinoma: A Case Report

Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non–small cell lung cancer (NSCLC) with limited treatment options and poor prognosis. EGFR mutations generally respond to tyrosine kinase inhibitors (TKIs)-based targeted therapy but are typically associated with resistance to...

Full description

Bibliographic Details

Published in:	Journal of Immunotherapy and Precision Oncology
Main Authors:	Ayushi Gianchandani, Darshana Desai, Janani Sambath, Darshana Patil, Prashant Kumar, Shambhavi Singh, Chetan Madre, Ruturaj Deshpande, Anjali Parab, Niyati Shah, Darshit Shah, Pritam Kataria, Shrikanth Atluri, Marzi Mehta, Aditya Shreenivas, Rajan Datar, Razelle Kurzrock, Sewanti Limaye
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2025-08-01
Online Access:	https://jipo.org/doi/pdf/10.36401/JIPO-25-7